Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCZ696 Dose-Ranging Study in Essential Hypertension
NCT00549770Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 2 trial of sacubitril + valsartan in essential hypertension, sponsored by Novartis. Started Sep 2007; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00549770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549770.